🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-526411-11-00
Withdrawn Phase I

A Safety Study to Test a New Medicine (ANT3310) Alone and When Taken with an Antibiotic (Meropenem) in Healthy Adult Participants.

2026-526411-11-00 · tracked via the Priya Life Science EU tracker
Sponsor
Antabio
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
12/06/2026
Enrollment target
40
Sites
France

Condition studied

Not applicable for phase I study

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-526411-11-00 on CTIS ↗ ← All trials in the EU